Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1678334

registered interest
date	15/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	DNA: Databases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure the security of DNA data held by (a) the NHS Genomic Medicine Service and (b) private providers of NHS healthcare; and whether she has had discussions with Cabinet colleagues on the potential for cyber attacks by foreign state-linked companies.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	7190
answer	answer is ministerial correction date of answer 19/12/2023 answer text <p>Organisations which hold sensitive biological data are subject to the UK General Data Protection Regulation. In addition, organisations such as Genomics England, UK Biobank and NIHR BioResource actively consider national security in decision making about partnerships with companies overseas.</p><p>As part of the new UK Biological Security Strategy, the Government is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy, without stifling innovation, and build confidence in sharing personal data to improve health outcomes in the United Kingdom and across the world. The Office for Life Sciences has begun this work, in consultation with relevant Departments and Agencies across Government, and key partners such as Genomics England and UK Biobank.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/12/2023 16:10:23 answering member 4044 label Biography information for Andrew Stephenson
tabling member	3960 label Biography information for Henry Smith

1678211

registered interest
date	14/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Trade Competitiveness
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she is taking steps to protect (a) Bupa, (b) HCA Healthcare and (c) other major private healthcare providers from (i) BGI Group and (ii) MGI Tech.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	7019
answer	answer is ministerial correction date of answer 19/12/2023 answer text <p>Organisations which hold sensitive biological data are subject to the UK General Data Protection Regulation (GDPR). In addition, organisations such as Genomics England, UK Biobank and NIHR BioResource actively consider national security in decision making about partnerships with companies overseas.</p><p>As part of the new UK Biological Security Strategy, the Government is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy, without stifling innovation, and build confidence in sharing personal data to improve health outcomes in the United Kingdom and across the world. The Office for Life Sciences has begun this work, in consultation with relevant Departments and Agencies across Government, and key partners such as Genomics England and UK Biobank.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/12/2023 16:02:28 answering member 4044 label Biography information for Andrew Stephenson
tabling member	3960 label Biography information for Henry Smith

1628302

registered interest
date	16/05/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gene Therapies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential support for UK leadership in the adoption of cell and gene therapies of the recommendations of the Cell and Gene Therapy Catapult’s National Cell and Gene Therapy Vision for the UK, published in March 2022.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	185241
answer	answer is ministerial correction date of answer 23/05/2023 answer text <p>The Department recognises that advanced cell and gene therapies will be an important part of the future of healthcare and the life sciences industry. We have been considering the recommendations of the Cell and Gene Therapy Catapult’s ‘National Cell and Gene Therapy Vision for the UK’, a report published by the Cell and Gene Therapy Catapult in March 2022 and the UK Strategic Stem Cell Forum’s latest report ‘A 10-year vision for stem cell transplantation and cellular therapies’ published in July 2022.</p><p>As part of this, we have been conducting stakeholder engagement to further understand the challenges raised and whether there is a role for the Department in coordinating activity in this area.</p> answering member constituency Colchester answering member printed Will Quince question first answered 23/05/2023 15:10:28 answering member 4423 label Biography information for Will Quince
tabling member	3960 label Biography information for Henry Smith

1586244

registered interest
date	17/02/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he will make an assessment of the impact of the removal of healthcare products and devices from the market due to price increase applications being rejected by NHS Supply Chains on the users of those products.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	146880
answer	answer is ministerial correction date of answer 27/02/2023 answer text <p>NHS Supply Chain (NHSSC) has robust measures in place to monitor supply chains and works closely with markets to ensure continuity of supply, so that the National Health Service has the medical devices and clinical consumables it needs to deliver care. Given the economic environment and global inflationary pressures, NHS Supply Chain recognises the challenges that suppliers are facing and is committed to working with them within the bounds of contractual agreements, to secure value for money for taxpayers and maintain availability.</p><p> </p><p>An established process exists for all price increase requests. These are evaluated by NHSSC on a case-by-case basis in line with the terms and conditions of awarded framework agreements. In order for an increase to be accepted, it needs to be justified and evidenced, and suppliers are expected to play their part in mitigating their cost pressures.</p><p> </p><p>With specific reference to energy costs, the Government remains committed to supporting businesses via the Energy Bill Relief Scheme which provides a discount on the wholesale element of gas and electricity bills to ensure that eligible non-domestic customers are protected from excessively high energy costs over the winter period. Following an HM Treasury led review, the new Energy Bill Discount Scheme will run from April until March 2024 and continue to provide a discount to eligible non-domestic customers.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 146881 146882 question first answered 27/02/2023 13:56:33 answering member 4423 label Biography information for Will Quince
tabling member	3960 label Biography information for Henry Smith

1586247

registered interest
date	17/02/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment: Costs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to support UK businesses that supply the NHS with medical devices, medical equipment and services impacted by additional costs in relating to (a) production, (b) distribution and (c) energy.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	146883
answer	answer is ministerial correction date of answer 02/03/2023 answer text <p>The Department and NHS Supply Chain (NHSSC) recognise challenges faced by suppliers relating to the economic environment and global inflationary pressures. The Government and NHSSC remain committed to working with suppliers within the bounds of contractual agreements, to secure value for money for taxpayers and maintain availability.</p><p> </p><p>With specific reference to energy costs, the Government is dedicated to supporting businesses via the Energy Bill Relief Scheme which provides a discount on the wholesale element of gas and electricity bills to ensure that eligible non-domestic customers are protected from excessively high energy costs over the winter period. Following an HM Treasury led review, the new Energy Bill Discount Scheme will run from April until March 2024 and continue to provide a discount to eligible non-domestic customers.</p> answering member constituency Colchester answering member printed Will Quince question first answered 02/03/2023 16:56:17 answering member 4423 label Biography information for Will Quince
tabling member	3960 label Biography information for Henry Smith

1469700

registered interest
date	13/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Meat: Novel Foods
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that regulatory approval is granted to safe, cultivated meat production in the UK.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	16914
answer	answer is ministerial correction date of answer 21/06/2022 answer text <p>Cultivated meat is considered a novel food and is therefore subject to an approval process. When a food business submits a novel food application, it will be assessed by the Food Standards Agency (FSA), with Food Standards Scotland (FSS). If the FSA, FSS and Ministers are satisfied the food is safe and appropriate for the market in Great Britain, the food will be approved. At this stage, the FSA and FSS have not received any applications for cultured meat products.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 21/06/2022 11:26:34 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1416776

registered interest
date	26/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Services: Food
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made, or plans to make, of the impact of the right to practise philosophical beliefs relating to diet on the mental wellbeing of those receiving care, in the context of the White Paper entitled People at the Heart of Care.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	112533
answer	answer is ministerial correction date of answer 02/02/2022 answer text <p>Local authorities should facilitate personalised care in line with their legal duties. The white paper states that personalised care should be the norm, allowing choice, control and support to live independent lives. This includes dietary requirements and preferences where appropriate.</p><p> </p><p><strong> </strong></p> answering member constituency Chichester answering member printed Gillian Keegan question first answered 02/02/2022 10:49:28 answering member 4680 label Biography information for Gillian Keegan
tabling member	3960 label Biography information for Henry Smith

1279365

registered interest
date	21/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that services for people with heart and circulatory diseases can be provided throughout the covid-19 outbreak to mitigate poorer health outcomes from delays to treatment.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	141422
answer	answer is ministerial correction date of answer 02/02/2021 answer text <p>On 23 December, NHS England and NHS Improvement published their operational priorities for winter and 2021/22. This confirms that maximising capacity in all settings to treat non-COVID-19 patients and responding to other emergency demands are key priorities for the National Health Service this winter. Cardiac services have been highlighted as a priority area for improvement through developing system-based recovery plans that focus on addressing treatment backlogs and long waits.</p><p> </p><p>To support the NHS in tackling the impact of COVID-19, a £3 billion, one-year package has been announced for 2021/22 as part of the Spending Review. This includes £1 billion to address backlogs and tackle long waiting lists, by facilitating up to one million extra checks, scans and additional operations. Additionally, the NHS is running an ongoing media campaign ‘Help us help you’, which includes clear messaging for patients to call 999 with symptoms of a heart attack or stroke. NHS services will continue to adapt to ensure that they are there for those who need them, as well as launching a major campaign urging people to come forward for help.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 141423 question first answered 02/02/2021 12:00:55 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1219228

registered interest
date	29/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Protective Clothing: Manufacturing Industries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he is taking steps with UK manufacturers to ensure that the country is self-sufficient in PPE production and supporting British enterprises; and if he will make a statement.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	66848
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>Lord Deighton is leading the Government effort to unleash the potential of British industry to manufacture personal protective equipment (PPE) for the health and social care sectors to create self-sufficient production of PPE for the United Kingdom. We are building up UK manufacturing with signed contracts to manufacture over 2 billion items of PPE through UK-based manufacturers, including facemasks, visors, gowns and aprons.</p><p>This includes Survitec, a survival technology company, who began producing gowns at the beginning of June; Bolle, who manufacture protective eyewear, will make 6.5 million visors over the course of the pandemic; Jaguar Land Rover are now manufacturing 14,000 visors/week for healthcare staff; Don &amp; Low will be manufacturing 12 million metres squared of fabric for gowns over the next six months, with the first delivery expected later this month; Burberry is manufacturing non-surgical gowns at its factory in Castleford and sourcing masks through its supply chain. To date, the company has donated over 100,000 pieces of PPE to the National Health Service and healthcare charities.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 17/07/2020 11:25:01 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1199798

registered interest
date	02/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to ensure that clinical criteria will be in place before further changes are made to the covid-19 shielding list.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	53401
answer	answer is ministerial correction date of answer 12/06/2020 answer text <p>The Chief Medical Officer (CMO) for England, working with the CMOs of the devolved administrations and other senior clinicians, commissioned NHS Digital to produce a list of vulnerable people at “high risk” of complications from COVID-19, who should be shielded for at least 12 weeks.</p><p>The next review point for the social distancing measures will take place the week commencing 15 June. As part of this, we will consider the next steps for shielding beyond 30 June. We will also review the risks for the clinically extremely vulnerable and assess whether the shielding period needs to be extended or whether it is possible for the shielding guidance to be eased further. We will base our assessment on clinical advice from our medical experts, and the best data available about the prevalence of COVID-19 in the community.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 12/06/2020 12:27:13 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith